https://www.selleckchem.com/pr....oducts/gusacitinib.h
5% (70/94) with unilateral tumor, and 44.7% (42/94) with mass sized 11-20 cm. In advanced OC, 63.8% (37/58) presented with ascites and omental carcinomatosis, 87.9% (51/58) without liver metastasis; and 5. Surgical outcome 55.3% (52/94) underwent primary cytoreductive surgery and 78.8% (41/52) had suboptimal surgical outcome. The characteristics of OC in the study population were different compared with the developed countries and the global population, i.e. the incidence of OC was most common among younger and premenopausal women.
Respect!
Kommentar
Delen
